Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 139 results.
User Information
Export Records
  1. 1.   Mosaic quadrivalent influenza vaccine single nanoparticle characterization
  2. Yang, Rong Sylvie; Traver, Maria; Barefoot, Nathan; Stephens, Tyler; Alabanza, Casper; Manzella-Lapeira, Javier; Zou, Guozhang; Wolff, Jeremy; Li, Yile; Resto, Melissa; Shadrick, William; Yang, Yanhong; Ivleva, Vera B; Tsybovsky,Yaroslav; Carlton, Kevin; Brzostowski, Joseph; Gall, Jason G; Lei, Q Paula
  3. Scientific Reports. 2024, Feb 24; 14(1): 4534.
  1. 2.   Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
  2. Li, Qing Kay; Hu, Yingwei; Chen, Lijun; Schnaubelt, Michael; Cui Zhou, Daniel; Li, Yize; Lu, Rita Jui-Hsien; Thiagarajan,Mathangi; Hostetter, Galen; Newton, Chelsea J; Jewell, Scott D; Omenn, Gil; Robles, Ana I; Mesri, Mehdi; Bathe, Oliver F; Zhang, Bing; Ding, Li; Hruban, Ralph H; Chan, Daniel W; Zhang, Hui
  3. Clinical proteomics. 2022, Oct 20; 19(1): 36.
  1. 3.   A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation
  2. Gulla, Krishana; Cibelli, Nicole; Cooper, Jonathan W.; Fuller, Haley C.; Schneiderman, Zachary; Witter, Sara; Zhang, Yaqiu; Changela, Anita; Geng, Hui; Hatcher, Christian; Narpala, Sandeep; Tsybovsky,Yaroslav; Zhang, Baoshan; McDermott, Adrian B.; Kwong, Peter D.; Gowetski, Daniel B.
  3. Vaccine. 2021, Jun 8; 39(25): 3379-3387.
  1. 4.   LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples
  2. Masood, M Athar; Veenstra, Timothy D
  3. Basic & clinical pharmacology & toxicology. 2020, Nov 01;
  1. 5.   Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry
  2. Cho, Kyung-Cho; Clark, David J.; Schnaubelt, Michael; Teo, Guo Ci; Leprevost, Felipe Veiga; Bocik,William; Boja, Emily S.; Hiltke, Tara; Nesvizhskii, Alexey; Zhang, Hui
  3. ANALYTICAL CHEMISTRY. 2020, Mar 17; 92(6): 4217-4225.
  1. 6.   Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy
  2. Hada, Manila; Oh, Hannah; Fan, Shaoqi; Falk, Roni T; Geller, Berta; Vacek, Pamela; Weaver, Donald; Shepherd, John; Wang, Jeff; Fan, Bo; Herschorn, Sally; Brinton, Louise A; Xu,Xia; Sherman, Mark E; Trabert, Britton; Gierach, Gretchen L
  3. Journal of clinical medicine. 2020, Jan 17; 9(1):
  1. 7.   Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes
  2. Watson, Dennis; Yung, Bryant C; Bergamaschi, Cristina; Chowdhury, Bhabadeb; Bear, Jenifer; Stellas, Dimitrios; Morales-Kastresana, Aizea; Jones, Jennifer C; Felber, Barbara; Chen, Xiaoyuan; Pavlakis, George
  3. Journal of Extracellular Vesicles. 2018, Feb 28; 7(1): 1442088.
  1. 8.   LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples
  2. Athar Masood, M; Veenstra, Timothy D
  3. Basic & Clinical Pharmacology & Toxicology. 2017, Aug 26;
  1. 9.   Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B approximately FIT Cohort
  2. Dallal, C. M.; Lacey, J. V., Jr.; Pfeiffer, R. M.; Bauer, D. C.; Falk, R. T.; Buist, D. S.; Cauley, J. A.; Hue, T. F.; LaCroix, A. Z.; Tice, J. A.; Veenstra, T. D.; Xu, X.; Brinton, L. A.
  3. Hormones & Cancer. 2016, Feb; 7(1): 49-64.
  1. 10.   Comparison of estrone and 17 beta-estradiol levels in commercial goat and cow milk
  2. Farlow, D. W.; Xu, X.; Veenstra, T. D.
  3. Journal of Dairy Science. 2012, Apr; 95(4): 1699-1708.
  1. 11.   Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization
  2. Chen, X. H.; Peer, C. J.; Alfaro, R.; Tian, T.; Spencer, S. D.; Figg, W. D.
  3. Journal of Pharmaceutical and Biomedical Analysis. 2012, Mar; 62: 140-148.
  1. 12.   Factors That Contribute to Assay Variation in Quantitative Analysis of Sex Steroid Hormones Using Liquid and Gas Chromatography-Mass Spectrometry
  2. Xu, X.; Veenstra, T. D.
  3. Journal of Chemical Education. 2012, Feb; 89(2): 230-233.
  1. 13.   A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma
  2. Peer, C. J.; Spencer, S. D.; VanDenBerg, D. A. H.; Pacanowski, M. A.; Horenstein, R. B.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2012, Jan; 880: 132-139.
  1. 14.   Analytical characterization of ch14.18 A mouse-human chimeric disialoganglioside-specific therapeutic antibody
  2. Soman, G.; Kallarakal, A. T.; Michiel, D.; Yang, X. Y.; Saptharishi, N.; Jiang, H. G.; Giardina, S.; Gilly, J.; Mitra, G.
  3. Mabs. 2012, Jan-Feb; 4(1): 84-100.
  1. 15.   Global proteomics and metabolomics in cancer biomarker discovery
  2. Issaq, H. J.; Fox, S. D.; Chan, K. C.; Veenstra, T. D.
  3. Journal of Separation Science. 2011, Dec; 34(24): 3484-3492.
  1. 16.   Molecular profiling of the human nasal epithelium: A proteomics approach
  2. Simoes, T.; Charro, N.; Blonder, J.; Faria, D.; Couto, F. M.; Chan, K. C.; Waybright, T.; Isaaq, H. J.; Veenstra, T. D.; Penque, D.
  3. Journal of Proteomics. 2011, Dec; 75(1): 56-69.
  1. 17.   Targeted mass spectrometry approaches for protein biomarker verification
  2. Meng, Z. J.; Veenstra, T. D.
  3. Journal of Proteomics. 2011, Nov; 74(12): 2650-2659.
  1. 18.   Challenges in plasma membrane phosphoproteomics
  2. Orsburn, B. C.; Stockwin, L. H.; Newton, D. L.
  3. Expert Review of Proteomics. 2011, Aug; 8(4): 483-494.
  1. 19.   A Reproducible and High-Throughput HPLC/MS Method To Separate Sarcosine from alpha- and beta-Alanine and To Quantify Sarcosine in Human Serum and Urine
  2. Meyer, T. E.; Fox, S. D.; Issaq, H. J.; Xu, X.; Chu, L. W.; Veenstra, T. D.; Hsing, A. W.
  3. Analytical Chemistry. 2011, Jul; 83(14): 5735-5740.
  1. 20.   Proteomics research in breast cancer: balancing discovery and hypothesis-driven studies
  2. Veenstra, T. D.
  3. Expert Review of Proteomics. 2011, Apr; 8(2): 139-141.
  1. 21.   A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo
  2. Hancock, C. N.; Stockwin, L. H.; Han, B. N.; Divelbiss, R. D.; Jun, J. H.; Malhotra, S. V.; Hollingshead, M. G.; Newton, D. L.
  3. Free Radical Biology and Medicine. 2011, Jan; 50(1): 110-121.
  1. 22.   Chromatographic methods for the quantification of free and chelated gadolinium species in MRI contrast agent formulations
  2. Clevel, D.; Long, S. E.; Sander, L. C.; Davis, W. C.; Murphy, K. E.; Case, R. J.; Rimmer, C. A.; Francini, L.; Patri, A. K.
  3. Analytical and Bioanalytical Chemistry. 2010, Dec; 398(7-8): 2987-2995.
  1. 23.   A new approach to measuring estrogen exposure and metabolism in epidemiologic studies
  2. Ziegler, R. G.; Faupel-Badger, J. M.; Sue, L. Y.; Fuhrman, B. J.; Falk, R. T.; Boyd-Morin, J.; Henderson, M. K.; Hoover, R. N.; Veenstra, T. D.; Keefer, L. K.; Xu, X.
  3. Journal of Steroid Biochemistry and Molecular Biology. 2010, Aug; 121(3-5): 538-545.
  1. 24.   Comparison of estrogens and estrogen metabolites in human breast tissue and urine
  2. Taioli, E.; Im, A.; Xu, X.; Veenstra, T. D.; Ahrendt, G.; Garte, S.
  3. Reproductive Biology and Endocrinology. 2010, Aug; 8: 7.
  1. 25.   Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography
  2. Moaddel, R.; Bighi, F.; Yamaguchi, R.; Patel, S.; Ravichandran, S.; Wainer, I. W.
  3. Analytical Biochemistry. 2010, Jun; 401(1): 148-153.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel